Accelerating the Future of Cell & Gene Therapy

At CytoNiche, we specialize in simplifying the complex world of CGT, especially mesenchymal stem/stromal cells (MSCs) to drive the success of therapeutic commercialization. Our solutions empower you to scale up production with cost-effective, high-quality cells, so that you can focus on what you do best —— developing transformative therapeutics. By optimizing access and affordability, we accelerate the timeline for bringing groundbreaking products to market.

See What Powers Us >

News & Events

More Events&News >

Dec 10,2025

ISCT 2026 Dublin

May 6–9, 2026 | Convention Centre Dublin, Ireland

Dec 10,2025

ISCT Asia Regional Meeting Singapore

September 2-5, 2026 | Suntec Convention Centre, Singapore

Dec 12,2025

Bridging Tradition and Technology: How Ginseng-Powered Nanovesicles Are Redefining Heart Attack Recovery

By integrating ginsenoside Rg1 with 3D-cultured MSCs, researchers created artificial cell-derived vesicles that significantly enhance myocardial protection by reducing oxidative stress and DNA damage.